Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy and Health Sciences, United States International University-Africa, Nairobi, Kenya.
Department of Pharmacy, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya.
Cancer Med. 2023 Feb;12(4):4147-4160. doi: 10.1002/cam4.5275. Epub 2022 Sep 29.
The incidence of gastrointestinal malignancies in Kenya is increasing, although there is a paucity of data on survival outcomes among gastric cancer patients. Hence, this study aimed to assess survival outcomes among adult gastric cancer patients at Kenyatta National Hospital.
A retrospective cohort study design was used to assess the survival outcomes among 247 gastric cancer patients. All medical records of adult (≥18 years) gastric cancer patients with complete medical records of diagnosis, stage of cancer, and treatment regimen in the study setting in the last 5 years (2016-2020) were included. A simple random sampling technique was employed to select the study participants. Data were collected using a data abstraction tool composed of socio-demographic and clinical characteristics. Survival outcomes were reported as the percentage of mortality, mean survival estimate, and mean cancer-specific survival. The data were entered and analyzed using version 20.0 SPSS statistical software. The mean survival estimates and predictors of mortality were computed using the Kaplan-Meier and Cox regression analysis.
The study showed that 33.3% (64) had new distant metastasis, and 42.1% (104) had disease progression. Besides, the mortality rate was high (33.6%), and 14.6% and 7.7% of patients had complete and partial responses, respectively. The five-year survival was 32.7% among gastric cancer patients. Comorbidity (p = 0.014), advanced-stage diseases (p = 0.03), chemotherapy (p = 0.008), and gastrectomy (p = 0.016) were significant determinants of mortality.
A significant proportion of patients had distant metastasis, disease progression, and a low five-year survival rate. Hence, early cancer-screening programs are indispensable to circumvent disease progression and improve survival outcomes.
肯尼亚胃肠道恶性肿瘤的发病率正在上升,尽管胃癌患者的生存结果数据很少。因此,本研究旨在评估肯尼亚国家医院成人胃癌患者的生存结果。
采用回顾性队列研究设计评估 247 例胃癌患者的生存结果。所有在研究环境中诊断为成人(≥18 岁)胃癌且病历完整、癌症分期和治疗方案完整的患者的病历均包括在内,时间跨度为过去 5 年(2016-2020 年)。采用简单随机抽样技术选择研究参与者。使用由社会人口统计学和临床特征组成的数据提取工具收集数据。生存结果以死亡率百分比、平均生存估计和平均癌症特异性生存报告。数据使用版本 20.0 SPSS 统计软件进行输入和分析。使用 Kaplan-Meier 和 Cox 回归分析计算平均生存估计和死亡率预测因素。
研究表明,33.3%(64 人)出现新的远处转移,42.1%(104 人)出现疾病进展。此外,死亡率很高(33.6%),分别有 14.6%和 7.7%的患者完全和部分缓解。胃癌患者的五年生存率为 32.7%。合并症(p=0.014)、晚期疾病(p=0.03)、化疗(p=0.008)和胃切除术(p=0.016)是死亡的显著决定因素。
相当一部分患者出现远处转移、疾病进展和低五年生存率。因此,早期癌症筛查计划对于避免疾病进展和改善生存结果至关重要。